Results 171 to 180 of about 52,371 (280)

Sinonasal Malignancies in Taiwan (2009–2019): Histologic Distribution, Overall Survival, and Temporal Trends in Hematological Versus Nonhematological Tumors

Laryngoscope Investigative Otolaryngology, Volume 11, Issue 5, October 2026.
ABSTRACT Background Sinonasal malignancies are rare and histologically diverse, with limited population‐based data from Asia. This study investigated the histologic distribution, factors associated with overall survival (OS), and temporal survival patterns in Taiwan.
Chi‐Hsien Wu, Ching‐Heng Lin, Kai‐Li Liang   +2 more
wiley   +1 more source

Primary Diffuse Large B-Cell Lymphoma of the Female Genital Tract: A Rare Case Presentation With Literature Review. [PDF]

Case Rep Hematol
Xu F, Lee JLJ, Yi B, Chen W.
europepmc   +1 more source

Fas expression in DLBCL [PDF]

American Journal of Hematology, 2007
Victor Piana de Andrade, Fernando Augusto Soares   +1 more
openaire   +1 more source

Investigating DLBCL Cell-Microenvironment Interactions Using a Biological 3D In Vitro Model: Insights into Cell Adhesion, Drug Response and Fluidic System Set Up

reservedIl linfoma diffuso a grandi cellule B (DLBCL) è il linfoma non-Hodgkin più comune, rappresentando circa il 30% dei casi a livello mondiale. Il trattamento di prima linea con terapia R-CHOP porta alla remissione completa nel 70% dei casi, mentre
PIANALTO, SABRINA
core  

Bruton's Tyrosine Kinase Inhibitors: Mechanisms, Efficacy, Toxicities and Applications for the Treatment of Human Diseases

MedComm, Volume 7, Issue 10, October 2026.
BTK inhibitors suppress malignant B‐cell signaling while simultaneously reshaping immune regulation through effects on T cells and the tumor microenvironment. These mechanisms support combination immunotherapy strategies and also underlie the expanding application of BTK inhibitors in solid tumors, autoimmune and inflammatory diseases.
Miao Sun, Dengju Li, Jia Wei
wiley   +1 more source

Advancing In Vivo Chimeric Antigen Receptor T‐Cell Engineering to Accelerate Clinical Translation

MedComm, Volume 7, Issue 10, October 2026.
In vivo CAR‐T cell generation directly engineers endogenous T cells using pre‐manufactured gene delivery vectors that target T cells and deliver CAR‐encoding genetic material. The resulting CAR‐T cells expand in vivo and mediate antigen‐specific cytotoxicity.
Zhenxin Bai, Ming Yi, Shengtao Hu, Dixuan Xue, Luxin Wei, Lifeng Zhang, Zhijun Dai   +6 more
wiley   +1 more source

ctDNA predicts outcomes in DLBCL [PDF]

Nature Reviews Clinical Oncology, 2018
openaire   +2 more sources

Fumarate and Its Esters: Physiology, Pathology, Molecular Mechanisms, Diseases, and Therapy

MedComm, Volume 7, Issue 10, October 2026.
Fumarate is an endogenous immunometabolite that regulates metabolism, redox homeostasis, and inflammation. Although fumaric acid esters (FAEs) share several molecular targets with fumarate, their distinct physicochemical properties confer unique biological activities and therapeutic applications.
Peng Zhu, Mengling You, Yi Zeng, Jinglin Zhang, Si Chen, Rong Rong, Xiaobo Xia   +6 more
wiley   +1 more source

PD-L1 Expression and Clinicopathologic Associations in Mediastinal Aggressive Large B-Cell Lymphomas: A Retrospective Single-Center Study. [PDF]

Diagnostics (Basel)
Kaymaz S, Cin S, Elverdi T, Akı SH, Demiröz AS.   +4 more
europepmc   +1 more source

Nanomedicine applications in lymphoma: Advancing precision diagnostics, targeted therapeutics, and prospective developments

VIEW, Volume 7, Issue 5, October 2026.
Lymphoma is a group of blood cancers that can appear in lymph nodes, blood, bone marrow, spleen, liver, or the central nervous system, which makes drug delivery and disease monitoring difficult. This review summarizes how nanomedicine technologies may improve targeted treatment and imaging, while carefully separating approved or guideline‐supported ...
Mohd Ahmar Rauf, Yara Mashal, Afeefa Rao, Nasar Ata, Arun K. Iyer, Farhan Shah   +5 more
wiley   +1 more source